ArticleCancer immunology, immunotherapy : CII2023

HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia.

Hana Komic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.